Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
von Hippel-Lindau Disease
×
lenvatinib
×
Clear all
Filters
3
NCT07405164
2026-04-17
MK-6482-043
Merck Sharp & Dohme LLC
Phase 3
Recruiting
450 enrolled